Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings
NASDAQ·Healthcare·Biotechnology
$0.20
-1.78%
Mkt Cap $6.34M
No upcoming LIMN earnings call has been scheduled. The most recent Liminatus Pharma, Inc. Cl earnings call was last-quarter on Tuesday, March 31, 2026, when EPS came in at -$0.03.
View LIMN earnings dates & historyEPS — Estimate vs Actual
Mkt Cap
$6.34M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.91